p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
暂无分享,去创建一个
Gregory McAllister | Ranjit Randhawa | William Forrester | Tripti Kulkarni | Ricardo Dolmetsch | Ajamete Kaykas | R. Dolmetsch | A. Kaykas | W. Forrester | M. Salick | Ranjit Randhawa | J. Reece-Hoyes | Kathleen A. Worringer | G. Hoffman | Elizabeth Frias | Carsten Russ | Chaoyang Ye | Zinger Yang | Elizabeth Frias | Max R Salick | Kraig Theriault | Zinger Yang | Carsten Russ | Chaoyang Ye | John Reece-Hoyes | Kraig M. Theriault | Robert J Ihry | Kathleen A Worringer | Daniel Ho | Sravya Kommineni | Julie Chen | Marie Sondey | Gregory R Hoffman | Sravya Kommineni | Daniel J. Ho | Gregory McAllister | Julie T. Chen | M. Sondey | Tripti Kulkarni | John Reece-Hoyes
[1] Steven Lin,et al. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery , 2014, eLife.
[2] U. Moll,et al. Links between mutant p53 and genomic instability , 2012, Journal of cellular biochemistry.
[3] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[4] Y. Liu,et al. Gene targeting in human pluripotent stem cells. , 2011, Methods in molecular biology.
[5] R. Jaenisch,et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases , 2009, Nature Biotechnology.
[6] T. Golub,et al. Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting. , 2016, Cancer discovery.
[7] L. Banaszynski,et al. A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules , 2006, Cell.
[8] Luigi Naldini,et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery , 2007, Nature Biotechnology.
[9] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[10] Zengrong Zhu,et al. An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells. , 2014, Cell stem cell.
[11] R. Jaenisch,et al. Induced Pluripotent Stem Cells Meet Genome Editing. , 2016, Cell stem cell.
[12] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[13] John A. Tallarico,et al. Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62 , 2016, eLife.
[14] R. Handsaker,et al. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations , 2017, Nature.
[15] L. Vassilev,et al. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.
[16] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[17] Y Taya,et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.
[18] Jeffrey A. Porter,et al. CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency , 2016, Science.
[19] D. Lane,et al. p53, guardian of the genome , 1992, Nature.
[20] Yang Xu,et al. Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. , 2010, Cell stem cell.
[21] Xin Li,et al. A comparison of non-integrating reprogramming methods , 2014, Nature Biotechnology.
[22] S. Jaeger,et al. Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer , 2014, Journal of biomolecular screening.
[23] Eli J. Fine,et al. DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.
[24] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[25] Sam W. Lee,et al. The guardian of the genome , 2015, Science.
[26] Davide Heller,et al. STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..
[27] D. Durocher,et al. High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities , 2015, Cell.
[28] T. Ichisaka,et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.
[29] L. Pevny,et al. Human embryonic stem cells have constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis. , 2012, Molecular cell.
[30] A. Letai,et al. High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis. , 2013, Cell stem cell.
[31] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[32] James A. Thomson,et al. Homologous recombination in human embryonic stem cells , 2003, Nature Biotechnology.
[33] T. Nomura,et al. Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis , 1999, Oncogene.
[34] E. Lander,et al. Identification and characterization of essential genes in the human genome , 2015, Science.
[35] R. Dolmetsch,et al. A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients , 2016, eLife.
[36] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[37] Ahmed Enayetallah,et al. Causal reasoning on biological networks: interpreting transcriptional changes , 2012, Bioinform..
[38] M. Savio,et al. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. , 2010, Mutation research.
[39] J. Doudna,et al. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.
[40] David A. Scott,et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.
[41] Hui Zhao,et al. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair , 2016, Nucleic acids research.
[42] K. Eggan,et al. Genetic Ablation of AXL Does Not Protect Human Neural Progenitor Cells and Cerebral Organoids from Zika Virus Infection. , 2016, Cell stem cell.
[43] Jiong Wu,et al. Regulation of Apoptosis and Differentiation by p53 in Human Embryonic Stem Cells* , 2007, Journal of Biological Chemistry.
[44] David A. Scott,et al. Rationally engineered Cas9 nucleases with improved specificity , 2015, Science.
[45] James A. Gagnon,et al. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus. , 2015, Cell reports.
[46] Namritha Ravinder,et al. Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection. , 2015, Journal of biotechnology.
[47] Joshua M. Korn,et al. CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions. , 2016, Cancer discovery.
[48] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[49] N. Benvenisty,et al. Pluripotent stem cells in disease modelling and drug discovery , 2016, Nature Reviews Molecular Cell Biology.